Also, INZ sensitizes the anti-cancer effect of cisplatin, doxorubicin, or Nutlin-3 (an MDM2 inhibitor) as tested in xenograft cancer models (Zhang et al., 2012c; Zhang et al, 2013). Here, MDM2 is linked to cancer.